6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine

C139H162B2BrCl6F2IN36O17S3 — CID 167636297

About 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine

6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine (PubChem CID 167636297) has the molecular formula C139H162B2BrCl6F2IN36O17S3 and a molecular weight of 3184.41 g/mol. Its IUPAC name is 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine.

Molecular Properties

• Compound Name: 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine
• PubChem CID: 167636297
• Molecular Formula: C139H162B2BrCl6F2IN36O17S3
• Molecular Weight: 3184.41 g/mol
• Exact Mass: 3178.86
• IUPAC Name: 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine
• SMILES: Brc1ccc2ccnn2c1.CC1(C)OB(c2cnn(CCN3CCOCC3)c2)OC1(C)C.CS(=O)(=O)Cc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(-c2ccc(F)cc2F)n1.CS(=O)(=O)Cc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(Cl)n1.CS(N)(=O)=O.ClCCN1CCOCC1.Clc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(Cl)n1.Ic1cnn2cc(-c3cnn(CCN4CCOCC4)c3)ccc12.OB(O)c1cc(Cl)nc(Cl)c1.c1cc2ccc(-c3cnn(CCN4CCOCC4)c3)cn2n1
• InChI: InChI=1S/C29H28F2N6O3S.C23H25ClN6O3S.C21H20Cl2N6O.C16H18IN5O.C16H19N5O.C15H26BN3O3.C7H5BrN2.C6H12ClNO.C5H4BCl2NO2.CH5NO2S/c1-41(38,39)19-24-12-21(13-28(34-24)25-4-3-23(30)14-27(25)31)26-16-33-37-18-20(2-5-29(26)37)22-15-32-36(17-22)7-6-35-8-10-40-11-9-35;1-34(31,32)16-20-10-18(11-23(24)27-20)21-13-26-30-15-17(2-3-22(21)30)19-12-25-29(14-19)5-4-28-6-8-33-9-7-28;22-20-9-16(10-21(23)26-20)18-12-25-29-14-15(1-2-19(18)29)17-11-24-28(13-17)4-3-27-5-7-30-8-6-27;17-15-10-19-22-12-13(1-2-16(15)22)14-9-18-21(11-14)4-3-20-5-7-23-8-6-20;1-2-16-3-4-17-21(16)13-14(1)15-11-18-20(12-15)6-5-19-7-9-22-10-8-19;1-14(2)15(3,4)22-16(21-14)13-11-17-19(12-13)6-5-18-7-9-20-10-8-18;8-6-1-2-7-3-4-9-10(7)5-6;7-1-2-8-3-5-9-6-4-8;7-4-1-3(6(10)11)2-5(8)9-4;1-5(2,3)4/h2-5,12-18H,6-11,19H2,1H3;2-3,10-15H,4-9,16H2,1H3;1-2,9-14H,3-8H2;1-2,9-12H,3-8H2;1-4,11-13H,5-10H2;11-12H,5-10H2,1-4H3;1-5H;1-6H2;1-2,10-11H;1H3,(H2,2,3,4)
• InChIKey: ONGVZPMRQSNGEA-UHFFFAOYSA-N
• XLogP: 16.58
• TPSA: 536.93 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 52
• Rotatable Bonds: 35
• Heavy Atoms: 207
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3184.41
LogP ≤ 5	16.58
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	52

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine?

The IUPAC name of 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine (CID 167636297) is 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine.

What is the SMILES notation for 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine?

The canonical SMILES for 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine is Brc1ccc2ccnn2c1.CC1(C)OB(c2cnn(CCN3CCOCC3)c2)OC1(C)C.CS(=O)(=O)Cc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(-c2ccc(F)cc2F)n1.CS(=O)(=O)Cc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(Cl)n1.CS(N)(=O)=O.ClCCN1CCOCC1.Clc1cc(-c2cnn3cc(-c4cnn(CCN5CCOCC5)c4)ccc23)cc(Cl)n1.Ic1cnn2cc(-c3cnn(CCN4CCOCC4)c3)ccc12.OB(O)c1cc(Cl)nc(Cl)c1.c1cc2ccc(-c3cnn(CCN4CCOCC4)c3)cn2n1.

What is the InChIKey of 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine?

The InChIKey is ONGVZPMRQSNGEA-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H28F2N6O3S.C23H25ClN6O3S.C21H20Cl2N6O.C16H18IN5O.C16H19N5O.C15H26BN3O3.C7H5BrN2.C6H12ClNO.C5H4BCl2NO2.CH5NO2S/c1-41(38,39)19-24-12-21(13-28(34-24)25-4-3-23(30)14-27(25)31)26-16-33-37-18-20(2-5-29(26)37)22-15-32-36(17-22)7-6-35-8-10-40-11-9-35;1-34(31,32)16-20-10-18(11-23(24)27-20)21-13-26-30-15-17(2-3-22(21)30)19-12-25-29(14-19)5-4-28-6-8-33-9-7-28;22-20-9-16(10-21(23)26-20)18-12-25-29-14-15(1-2-19(18)29)17-11-24-28(13-17)4-3-27-5-7-30-8-6-27;17-15-10-19-22-12-13(1-2-16(15)22)14-9-18-21(11-14)4-3-20-5-7-23-8-6-20;1-2-16-3-4-17-21(16)13-14(1)15-11-18-20(12-15)6-5-19-7-9-22-10-8-19;1-14(2)15(3,4)22-16(21-14)13-11-17-19(12-13)6-5-18-7-9-20-10-8-18;8-6-1-2-7-3-4-9-10(7)5-6;7-1-2-8-3-5-9-6-4-8;7-4-1-3(6(10)11)2-5(8)9-4;1-5(2,3)4/h2-5,12-18H,6-11,19H2,1H3;2-3,10-15H,4-9,16H2,1H3;1-2,9-14H,3-8H2;1-2,9-12H,3-8H2;1-4,11-13H,5-10H2;11-12H,5-10H2,1-4H3;1-5H;1-6H2;1-2,10-11H;1H3,(H2,2,3,4).

What are the key properties of 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine?

6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine has a molecular weight of 3184.41 g/mol, XLogP of 16.58, 35 rotatable bonds, 3 hydrogen bond donors, and 52 hydrogen bond acceptors.

Where does this data come from?

All data for 6-bromopyrazolo[1,5-a]pyridine;4-(2-chloroethyl)morpholine;4-[2-[4-[3-[2-chloro-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;(2,6-dichloro-4-pyridinyl)boronic acid;4-[2-[4-[3-(2,6-dichloro-4-pyridinyl)pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-[3-[2-(2,4-difluorophenyl)-6-(methylsulfonylmethyl)-4-pyridinyl]pyrazolo[1,5-a]pyridin-6-yl]pyrazol-1-yl]ethyl]morpholine;4-[2-[4-(3-iodopyrazolo[1,5-a]pyridin-6-yl)pyrazol-1-yl]ethyl]morpholine;methanesulfonamide;4-[2-(4-pyrazolo[1,5-a]pyridin-6-ylpyrazol-1-yl)ethyl]morpholine;4-[2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl]morpholine is sourced from PubChem (CID 167636297), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).